Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00525057 · OUTCOME

Post-Operative Blood Transfusion

Dalteparin in Preventing DVT in Participants With Cancer · Source last updated 2021-01-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
mL
Interval / dispersion
95% Confidence Interval
Time frame
4 weeks after surgery

What was measured

The volume of packed red blood cell transfusion in the post-operative period

Groups in this outcome

Interventional (Dalteparin, Metastatic)

Received dalteparin 5000 units daily postop, patients with metastatic disease.

Interventional (Dalteparin, Sarcoma)

Received dalteparin 5000 units daily postop, patients with primary sarcomas.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Interventional (Dalteparin, Metastatic)25
Interventional (Dalteparin, Sarcoma)25

Reported measurements

Source class 1
Values in mL · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Interventional (Dalteparin, Metastatic)213Not reported0685Not reported
Interventional (Dalteparin, Sarcoma)271Not reported02059Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        685
        value
        213
      2. group Id
        OG001
        lower Limit
        0
        upper Limit
        2059
        value
        271
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    2. group Id
      OG001
      value
      25
    units
    Participants
description
The volume of packed red blood cell transfusion in the post-operative period
dispersion Type
95% Confidence Interval
groups
  1. description
    Received dalteparin 5000 units daily postop, patients with metastatic disease.
    id
    OG000
    title
    Interventional (Dalteparin, Metastatic)
  2. description
    Received dalteparin 5000 units daily postop, patients with primary sarcomas.
    id
    OG001
    title
    Interventional (Dalteparin, Sarcoma)
param Type
MEAN
reporting Status
POSTED
time Frame
4 weeks after surgery
title
Post-Operative Blood Transfusion
type
SECONDARY
unit Of Measure
mL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice